Bioresource of Cervical Tissue Explants from Healthy Women

by James M. Fox, Rebecca C. Wiggins, Charles J. Lacey
Published 2018-09-01

MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide.

by Georgina C Morris, Rebecca C Wiggins, Sarah C Woodhall, J Martin Bland, Carol R Taylor, Vicky Jespers, Brigitta A Vcelar, Charles J Lacey
Published 2014-01-01

Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally.

by David J Lewis, Carol A Fraser, Abdel N Mahmoud, Rebecca C Wiggins, Maria Woodrow, Alethea Cope, Chun Cai, Rafaela Giemza, Simon A Jeffs, Maria Manoussaka, Tom Cole, Martin P Cranage, Robin J Shattock, Charles J Lacey
Published 2011-01-01